PubRank

Jacqueline Witteman

Author PubWeight™ 50.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010 16.96
2 Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis 2008 7.45
3 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
4 Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet 2011 1.92
5 Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010 1.90
6 Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 2009 1.72
7 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
8 The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med 2013 1.70
9 Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet 2011 1.68
10 Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet 2012 1.14
11 Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol 2011 1.03
12 Association of atherosclerosis with presence and progression of osteoarthritis: the Rotterdam Study. Ann Rheum Dis 2012 0.99
13 Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium. Eur Heart J 2012 0.92
14 Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. Am Heart J 2010 0.90
15 Changes in HDL cholesterol and cardiovascular outcomes after lipid modification therapy. Heart 2012 0.88
16 Genetic architecture of circulating lipid levels. Eur J Hum Genet 2011 0.88
17 Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol 2010 0.86
18 Risk factors for out-of-hospital cardiac arrest: the Reykjavik Study. Eur Heart J 2005 0.84
19 Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease. J Hypertens 2010 0.83
20 Common variants in Mendelian kidney disease genes and their association with renal function. J Am Soc Nephrol 2013 0.82
21 Automatic quantification of epicardial fat volume on non-enhanced cardiac CT scans using a multi-atlas segmentation approach. Med Phys 2013 0.81
22 Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Hypertension 2009 0.81
23 Aging and left ventricular mass and function in people with end-stage renal disease. J Am Geriatr Soc 2011 0.77
24 Impact of thyroid function and polymorphisms in the type 2 deiodinase on blood pressure: the Rotterdam Study and the Rotterdam Scan Study. Clin Endocrinol (Oxf) 2008 0.76
25 Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD). J Nephrol 2012 0.76